3,5-Di-t-Butylcatechol as a Ryanodine Receptor Agonist in Rat Intact Skeletal Muscle Fibers

[摘要]：Strategy, Management and Health Policy Enabling Technology, Genomics, Proteomics Preclinical Research Preclinical Development Toxicology, Formulation Drug Delivery, Pharmacokinetics Clinical Development Phases I-III Regulatory, Quality, Manufacturing Post

[全文传递流程]：

一般上传文献全文的时限在1个工作日内